Clinical trial
Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00099060 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00099060 |
|---|---|
| Title | Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme |
| Official title | A Phase I/II Study of GW572016 in Patients With Recurrent Malignant Glioma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | NCIC Clinical Trials Group |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | lapatinib ditosylate |
| Enrollment | 24 |
| Start date | Dec 1, 2004 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Dec 9, 2004 |
| Last update posted | Jan 27, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: